Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines

スポンサーリンク

概要

• 論文の詳細を見る

著者

• MORI Shinichiro

  Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital

• MEGURO KUNIAKI

  National Sendai Hospital

• Minauchi Koichiro

  Second Department Of Medicine Hokkaido University Graduate School Of Medicine

• Takahashi Masatomo

  聖マリアンナ医科大学 血液･腫瘍内科

• Tanimoto M

  Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of

• Tanimoto Mitsune

  国立がんセンター中央病院 造血幹細胞移植グループ

• ABE Akihiro

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• TANIMOTO Mitsune

  First Department of Internal Medicine, Nagoya University School of Medicine

• Abe Akihiro

  名古屋市立大学 医学系研究科血液腫瘍内科学

• Tanimoto Mitsune

  名古屋大学 第1内科

• Meguro Kuniaki

  東北大学 医学部分子診断学

• SAITO Hidehiko

  Aichi Cancer Center Hospital

• Soda Hisashi

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• EMI Nobuhiko

  First Department of Internal Medicine

• Emi Nobuhiko

  名古屋大学 医学系研究科血液･腫瘍内科学

• Emi Nobuhiko

  First Department Of Internal Medicine Nagoya University Graduate School Of Medicine

• Emi Nobuhiko

  The First Department Of Internal Medicine Nagoya University School Of Medicine

• Miyamura Koichi

  Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine

• Miyamura K

  Tohoku Univ. School Of Medicine Sendai Jpn

• Miyamoto Ken-ichi

  Department Of Hematology Japanese Red Cross Nagoya First Hospital

• Miyamura Koichi

  First Department Of Internal Medicine Nagoya University School Of Medicine

• ITOU Toshihide

  First Department of Internal Medicine, Nagoya University School of Medicine

• ABE Akihiro

  First Department of Internal Medicine, Nagoya University School of Medicine

• TERASAKI Hiroshi

  Department of Cytogenetic Analysis, Mitsubishi Kagaku Bioclinical Laboratory Inc.

• SHIMADZU Mitsunobu

  Department of Cytogenetic Analysis, Mitsubishi Kagaku Bioclinical Laboratory Inc.

• Miyazawa Keisuke

  Department Of Hematology Tokyo Medical University

• Tanimoto Mitsune

  First Department Of Internal Medicine Nagoya University School Of Medicine

• TAJI Hirofumi

  Japanese Red Cross Nagoya First Hospital

• Taji H

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Abe A

  Department Of Applied Chemistry Tokyo Polytechnic University

• Abe Akihiro

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Abe Akihiro

  First Department Of Internal Medicine Graduate Of Medicine Nagoya University

• Itou Toshihide

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Shimadzu M

  Mitsubishi Kagaku Bio‐clinical Lab. Tokyo Jpn

• Emi N

  Department Of Hematology Nagoya University Graduate School Of Medicine

関連論文

• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
• Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
• Successful treatment of minimal residual disease-positive Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib followed by reduced-intensity unrelated cord blood transplantation after allogeneic peripheral blood stein cell transplan
• Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation
• 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
• In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
• Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
• 点欠陥の自己組織化的挙動を利用した微細構造形成法
• イオン照射で導入される点欠陥を利用したナノセル構造の形成
• イオン照射によって導入された点欠陥によるセル構造の形成
• イオン照射による半導体微細セル構造の自己組織化形成
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Surface Sink Effects on Void Formation in GaSb and InSb under Ion Irradiation
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
• Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
• Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
• Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
• High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
• Progressive osteosclerosis and visceral calcification after cord blood transplantation
• Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Case-control study of leukemia and diagnostic radiation exposure
• Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
• Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
• Successful cord blood transplantation for mycosis fungoides.
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Human T cell leukemia virus type-1 Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-kB pathway
• Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
• Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
• Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
• Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
• The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia
• Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression
• In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi-scid/scid Mice
• Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
• Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
• Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
• Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
• Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
• Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
• A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
• Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
• Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
• Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T-Cell Leukemia
• Recovery of Hematopoietic Progenitor Cells in Patients With Severe Aplastic Anemia Who Obtained Good Clinical Response With a Combination Therapy of Immunosuppressive Agents and Recombinant Human Granulocyte Colony-Stimulating Factor
• Kaposi's sarcoma - associated herpesvirus-like DNA sequences are not present in adult T-cell leukemia
• A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
• Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
• Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
• A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
• Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
• Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
• Real-Time Polymerase Chain Reaction for Quantification of HTLV-1 Proviral Load: Application for Analyzing Aberrant Integration of the Proviral DNA in Adult T-Cell Leukemia
• Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
• Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
• Nucleotide Alteration of Retinoblastoma Protein-Interacting Zinc Finger Gene, RIZ, in Human Leukemia
• Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
• Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
• Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
• Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
• Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia
• Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells
• Anti-AnWj antibody in a case with non-Hodgkin lymphoma
• Dexamethasone Reduces the Risk of Bortezomib-Induced Pulmonary Complications in Japanese Myeloma Patients
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
• Successful Nonmyeloablative Bone Marrow Transplantation for Leukocyte Adhesion Deficiency Type I from an Unrelated Donor
• Significance of Decreased Plasma D-Dimer Levels following Lipopolysaccharide-Induced Disseminated Intravascular Coagulation in Rats
• Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
• Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
• Serologically HLA-DR-Mismatched Unrelated Donors Might Provide a Valuable Alternative in Allogeneic Transplantation : Experience from a Single Japanese Institution
• Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
• Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
• CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy
• Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
• Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
• Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
• Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
• Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
• Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
• Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
• An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)

もっと見る 閉じる

スポンサーリンク